China NT Pharma Group Company Limited (HKG:1011)
Hong Kong
· Delayed Price · Currency is HKD
0.730
0.00 (0.00%)
At close: Mar 10, 2026
HKG:1011 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 492 | 71 | 145 | 171 | 135 | 229 | |
| Market Cap Growth | 699.90% | -50.91% | -15.27% | 26.76% | -40.83% | -27.27% | |
| Enterprise Value | 834 | 445 | 993 | 1,082 | 992 | 1,420 | |
| Last Close Price | 0.73 | 0.27 | 0.55 | 0.90 | 0.71 | 1.20 | |
| Forward PE | - | 15.33 | 15.33 | 15.33 | 15.33 | 15.33 | |
| PS Ratio | 24.07 | 1.77 | 17.90 | - | 0.49 | 0.87 | |
| PB Ratio | -1.62 | -0.17 | -0.39 | -0.63 | -0.52 | 8.58 | |
| P/FCF Ratio | - | - | 3.32 | 4.78 | - | 81.55 | |
| P/OCF Ratio | - | - | 2.61 | 4.19 | - | 7.34 | |
| EV/Sales Ratio | 40.80 | 11.01 | 122.42 | - | 3.57 | 5.39 | |
| EV/FCF Ratio | -33.48 | - | 22.69 | 30.19 | - | 506.69 | |
| Debt / Equity Ratio | -1.14 | -0.94 | -1.02 | -3.42 | -3.94 | 37.97 | |
| Debt / FCF Ratio | - | - | 8.68 | 26.06 | - | 360.79 | |
| Net Debt / Equity Ratio | -1.13 | -0.92 | -1.01 | -3.39 | -3.89 | 37.63 | |
| Net Debt / EBITDA Ratio | -26.27 | -27.80 | -6.65 | -87.43 | -14.36 | -15.99 | |
| Net Debt / FCF Ratio | -13.72 | -39.63 | 8.64 | 25.87 | -6.05 | 357.53 | |
| Asset Turnover | 0.06 | 0.11 | 0.01 | - | 0.20 | 0.14 | |
| Inventory Turnover | - | - | - | - | 2.74 | 2.81 | |
| Quick Ratio | 0.05 | 0.01 | 0.02 | 0.05 | 0.05 | 0.35 | |
| Current Ratio | 0.05 | 0.02 | 0.02 | 0.06 | 0.30 | 0.50 | |
| Return on Equity (ROE) | - | - | - | - | - | -307.64% | |
| Return on Assets (ROA) | -2.18% | -2.49% | -5.26% | -1.69% | -5.19% | -2.95% | |
| Return on Invested Capital (ROIC) | -33.88% | - | -19.29% | -4.46% | -12.65% | -7.60% | |
| Return on Capital Employed (ROCE) | 4.30% | 3.40% | 16.70% | 16.20% | -157.40% | -52.70% | |
| Earnings Yield | -15.79% | -79.63% | -108.91% | -43.79% | -135.74% | -185.81% | |
| FCF Yield | -5.06% | -13.80% | 30.14% | 20.92% | -123.43% | 1.23% | |
| Buyback Yield / Dilution | -65.59% | -10.72% | -25.59% | -0.51% | -0.14% | -6.98% | |
| Total Shareholder Return | -65.59% | -10.72% | -25.59% | -0.51% | -0.14% | -6.98% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.